Agenus Announces Updated NEST Phase 2 Publication Reporting Deep Pathologic Responses and No Observed Recurrences with Neoadjuvant BOT+BAL in Resectable Colon Cancer
Business Wire•26/08/2026•10:05 ET
0
Whiz Insights
Get started
Create a free account to read the full story.